Skip to main content Accessibility help
×
Home

The role of hospital payments in the adoption of new medical technologies: an international survey of current practice

  • Corinna Sorenson (a1), Michael Drummond (a2), Aleksandra Torbica (a3), Giuditta Callea (a4) and Ceu Mateus (a5)...

Abstract

This study examined the role of prospective payment systems in the adoption of new medical technologies across different countries. A literature review was conducted to provide background for the study and guide development of a survey instrument. The survey was disseminated to hospital payment systems experts in 15 jurisdictions. Fifty-one surveys were disseminated, with 34 returned. The surveys returned covered 14 of the 15 jurisdictions invited to participate. The majority (71%) of countries update the patient classification system and/or payment tariffs on an annual basis to try to account for new technologies. Use of short-term separate or supplementary payments for new technologies occurs in 79% of countries to ensure adequate funding and facilitate adoption. A minority (43%) of countries use evidence of therapeutic benefit and/or costs to determine or update payment tariffs, although it is somewhat more common in establishing short-term payments. The main barrier to using evidence is uncertain or unavailable clinical evidence. Almost three-fourths of respondents believed diagnosis-related group systems incentivize or deter technology adoption, depending on the particular circumstances. Improvements are needed, such as enhanced strategies for evidence generation and linking evidence of value to payments, national and international collaboration and training to improve existing practice, and flexible timelines for short-term payments. Importantly, additional research is needed to understand how different payment policies impact technology uptake as well as quality of care and costs.

Copyright

Corresponding author

*Correspondence to: Corinna Sorenson, Research Fellow, LSE Health, London School of Economics and Political Science, Cowdray House, Houghton Street, London WC2A 2AE, UK. Email: c.sorenson@lse.ac.uk

References

Hide All
Barnum, H., Kutzin, J. and Saxenian, H. (1995), ‘Incentives and provider payment methods’, International Journal of Health Planning and Management, 10: 2345.
Busse, R., Geissler, A., Quentin, W. and Wiley, M. (2011), Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency, and Quality in Hospitals, New York: McGraw-Hill/Open University Press.
Cappellaro, G., Ghislandi, S. and Anessi-Pessina, E. (2011), ‘Diffusion of medical technology: the role of financing’, Health Policy, 100(1): 5159.
Chalkidou, K., Tunis, S., Wicher, D., Fowler, R. and Zwarenstein, M. (2012), ‘The role of pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research’, Clinical Trials, 9(4): 436446.
Clyde, A. T., Bockstedt, L., Farkas, J. A. and Jackson, C. (2008), ‘Experience with Medicare’s new technology add-on payment program’, Health Affairs, 27: 16321641.
Cutler, D. M. and McClellan, M. (2001), ‘Is technological change in medicine worth it?’, Health Affairs, 20: 1129.
Department of Health (2011), Payment by Results Guidance for 2010–2011. London: Department of Health.
Dreyer, N. A., Tunis, S. R., Berger, M., Ollendorf, D., Mattox, P. and Gliklich, R. (2010), ‘Why observational studies should be among the tools used in comparative effectiveness research’, Health Affairs, 29(10): 18181825.
Drummond, M. F., Griffin, A. and Tarricone, R. (2009), ‘Economic evaluation for devices and drugs. Same or different?’, Value in Health, 12(4): 402404.
Fulop, N., Allen, P., Clarke, A. and Black, N. (2003), ‘From health technology assessments to research on the organization and delivery of health care services: addressing the balance’, Health Policy, 63(2): 155165.
Greenhalgh, T., Roberts, G., MacFarlane, F., Bate, P. and Kyriakidou, O. (2004), ‘Diffusion of innovations in service organizations: systematic review and recommendations’, Milbank Quarterly, 82: 581629.
Henschke, C., Baumler, M., Weid, S., Gaskins, W. and Busse, R. (2010), ‘Extrabudgetary (“NUB”) payments: a gateway for introducing new medical devices into the German inpatient reimbursement system?’, Journal of Management & Marketing in Healthcare, 3: 119133.
Kesteloot, K. and Voet, N. (1998), ‘Incentives for cooperation in quality among hospitals – the impact of the reimbursement systems’, Journal of Health Economics, 17: 701728.
MedPAC (2003), ‘Payment for new technologies in Medicare’s prospective payment system’, In Report to the Congress: Medicare Payment Policy, Chapter 4. Washington, DC: Medicare Payment Advisory Commission.
MedPAC (2010), Aligning Incentives in Medicare, Washington, DC: MedPAC.
Mowatt, G., Bower, D. J., Brebner, J. A., Cairns, J. A., Grant, A. M. and McKee, L. (1997), ‘When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies’, Health Technology Assessment, 1: 1149.
Office of Technology Assessment (OTA) (1983), Diagnosis Related Groups (DRGs) and the Medicare Program: Implications for Medical Technology. A Technical Memorandum, Washington, DC: Office of Technology Assessment.
Scheller-Kreinsen, D., Quentin, W. and Busse, R. (2011), ‘DRG-based hospital payment systems and technological innovation in 12 European countries’, Value in Health, 14(8): 11661172.
Schreyogg, J., Baumler, M. and Busse, R. (2009), ‘Balancing adoption and affordability of medical devices in Europe’, Health Policy, 92: 218224.
Schreyogg, J., Stargardt, T., Tiemann, O. and Busse, R. (2006), ‘Methods to determine reimbursement rates for diagnosis related groups (DRGs): a comparison of nine European countries’, Health Care Management Science, 9: 215223.
Sorenson, C., Tarricone, R., Siebert, M. and Drummond, M. (2011), ‘Applying health economics for policy decision making: how much do devices differ from drugs?’, Europace, 13(2): 11541158.
Torbica, A. and Cappellaro, G. (2010), ‘Uptake and diffusion of medical technology innovation in Europe: What role for funding and procurement policies?’, Journal of Medical Marketing, 10(1): 6169.
Weisbrod, B. A. (1991), ‘The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment’, Journal of Economic Literature, 29: 523532.
Audit Commission (2008), The right result? Payment by Results 2003–2007, London: Audit Commission.
Bellanger, M. and Tadif, L. (2006), ‘Accounting and reimbursement schemes for inpatient care in France’, Health Care Management Science, 9: 295305.
Bocking, W., Ahrens, U., Kirch, W. and Milakovic, M. (2005), ‘First results of the introduction of DRGs in Germany and overview of experience form other DRG countries’, Journal of Public Health, 13(3): 128137.
Boyle, S. (2007), ‘Payment by results in England’, Eurohealth, 13(1): 1216.
Busse, R., Geissler, A., Quentin, W. and Wiley, M. (2011), Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency, and Quality in Hospitals, New York: McGraw-Hill/Open University Press.
Busse, R., Schreyogg, J. and Smith, P. (2006), ‘Hospital case payment systems in Europe’, Health Care Management Science, 9(3): 211213.
Cappellaro, G., Ghislandi, S. and Anessi-Pessina, E. (2011), ‘Diffusion of medical technology: The role of financing’, Health Policy, 100(1): 5159.
Cappellaro, G., Fattore, G. and Torbica, A. (2009), ‘Funding health technologies in decentralized systems: A comparison between Italy and Spain’, Health Policy, 92(2–3): 313321.
Clyde, A. T., Bockstedt, L., Farkas, J. A. and Jackson, C. (2008), ‘Experience with Medicare’s new technology add-on payment program’, Health Affairs, 27: 16321641.
Cots, F., Chiarello, P., Salvador, X. and Castells, X. (2012), ‘Patient classification systems and hospital costs of care for knee replacement in 10 European countries’, Health Economics, 21(S2): 116128.
Department of Health (2009), Payment by Results Guidance for 2009–2010, London: Department of Health.
Donaldson, C. and Magnussen, J. (1992), ‘DRGs: The road to hospital efficiency’, Health Policy, 21(1): 4764.
Ellis, R. P. and Vidal-Fernandez, M. (2007), ‘Activity-based payments and reforms of the English hospital payment system’, Health Economics, Policy and Law, 20(4): 435444.
Farrar, S., Yi, D., Sutton, M., Chalkley, M., Sussex, J. and Scott, A. (2009), ‘Has payment by results affected the way that English hospitals provide care? Difference-in-differences analysis’, BMJ, 339: b3047.
Fulop, N., Allen, P., Clarke, A. and Black, N. (2003), ‘From health technology assessments to research on the organization and delivery of health care services: addressing the balance’, Health Policy, 63: 155165.
Garrison, L. P. and Wilensky, G.R. (1986), ‘Cost containment and incentives for technology’, Health Affairs, 5(2): 4658.
Geissler, A., Scheller-Kreinsen, D. and Quentin, W. (2012), ‘Do diagnosis-related groups appropriately explain variations in costs and length of stay of hip replacement? A comparative assessment of DRG systems across 10 European countries’, Health Economics, 21(S2): 103115.
Goldfield, N. (2010), ‘The evolution of diagnosis-related groups (DRGs): from its beginning in case-mix and resource use theory, to its implementation for payment and now for its current utilization for quality within and outside the hospital’, Quality Management in Health Care, 19(1): 316.
Greenhalgh, T., Roberts, G., MacFarlane, F., Bate, P. and Kyriakidou, O. (2004), ‘Diffusion of innovations in service organizations: systematic review and recommendations’, Milbank Quarterly, 82: 581629.
Häkkinen, U., Chiarello, P., Cots, F., Peltola, M. and Rättö, H. (2012), ‘Patient classification and hospital costs of care for acute myocardial infarction in nine European countries’, Health Economics, 21(S2): 1929.
Henschke, C., Baumler, M., Weid, S., Gaskins, W. and Busse, R. (2010), ‘Extrabudgetary (“NUB”) payments: a gateway for introducing new medical devices into the German inpatient reimbursement system?’, J Management Marketing Healthcare, 3: 119133.
Hessel, F. (2005), ‘Reimbursement for high-priced innovative medical devices in a DRG-based hospital care system: The German situation’, Expert Review of Pharmacoeconomics and Outcomes Research, 5(4): 377381.
Hindle, D. and Lenz, M. J. (2001), ‘Using Australian DRGs in Germany: A commentary’, Australian Health Review, 24(1): 136147.
Jegers, M., Kesteloot, K., De Graeve, D. and Gilles, W. (2001), ‘A typology for provider payment systems in health care’, Health Policy, 60(3): 255273.
Kesteloot, K. and Voet, N. (1998), ‘Incentives for cooperation in quality among hospitals – the impact of the reimbursement systems’, J Health Econ, 17: 701728.
Leister, J. E. and Stausberg, J. (2005), ‘Comparison of cost accounting methods from DRG systems and their effect on health care quality’, Health Policy, 74(1): 4655.
Lungen, M., Dredge, B., Rose, A., Roebuck, C., Plamper, E., Lauterbach, K. and T. W. Group (2004), ‘Using diagnosis-related groups: The situation in the United Kingdom National Health Service and in Germany’, The European Journal of Health Economics, 5(4): 287289.
Mannion, R., Marini, G. and Street, A. (2008), ‘Implementing payment by results in the English NHS: changing incentives and the role of information’, Journal of Health Organization and Management, 22(1): 7988.
Medpac (2003), ‘Payment for new technologies in Medicare’s prospective payment system’, In Report to the Congress: Medicare Payment Policy, Chapter 4. Washington DC: Medicare Payment Advisory Commission.
Medpac (2001), ‘Accounting for new technology in hospital prospective payment systems’, In: Report to the Congress: Medicare Payment Policy, pg 3345. Washington DC: Medicare Payment Advisory Commission.
Medpac (2010), Aligning Incentives in Medicare, Washington, DC: Medicare Payment Advisory Commission.
Miraldo, M., Goddard, M. and Smith, P. (2006), The Incentive Effects of Payment by Results. CHE Research Paper 19, London: Dr. Foster Intelligence.
Office of Technology Assessment (1983), Diagnosis Related Groups (DRGs) and the Medicare Program: Implication for Medical Technology – A Technical Memorandum. Washington, DC: US Congress, Office of Technology Assessment.
Oostenbrink, J. B. and Rutten, F. F. (2006), ‘Cost assessment and price setting of inpatient care in the Netherlands: The DBC case-mix system’, Health Care Management Science, 9(3): 10091029.
Or, Z. (2009), ‘Activity based payment in France’, Euro Observer, 11(4): 56.
Robert, G., Greenhalgh, T., MacFarlane, F. and Peacock, R. (2010), ‘Adopting and assimilating new non-pharmaceutical technology into health care: a systematic review’, J Health Serv Res Policy, 15: 243250.
Roger, F. H. (2003), ‘Case mix use in 25 countries: A migration success but international comparison failure’, International Journal of Medical Informatics, 70(2–3): 215219.
Scheller-Kreinsen, D., Geissler, A. and Busse, R. (2009), ‘The ABC of DRGs’, Euro Observer, 11(4): 15.
Scheller-Kreinsen, D., Quentin, W. and Busse, R. (2011), ‘DRG-based hospital payment systems and technological innovation in 12 European countries’, Value in Health, 14(8): 11661172.
Schmid, A. and Gotze, R. (2009), ‘Cross-national policy learning in health system reform: The case of Diagnosis Related Groups’, International Social Security Review, 62: 2140.
Schreyogg, J., Baumler, M. and Busse, R. (2009), ‘Balancing adoption and affordability of medical devices in Europe’, Health Policy, 92: 218224.
Schreyogg, J., Stargardt, T., Tiemann, O. and Busse, R. (2006), ‘Methods to determine reimbursement rates for diagnosis related groups (DRGs): a comparison of nine European countries’, Health Care Management Science, 9: 215223.
Schreyogg, J., Tiemann, O. and Busse, R. (2006), ‘Cost accounting to determine prices: How well do prices reflect costs in the German DRG system?’, Health Care Management Science, 9: 269279.
Schreyogg, J., Tiemann, O. and Busse, R. (2005), ‘The DRG reimbursement system in Germany’, Euro Observer, 7(4): 46.
Shin, C. and Berliner, E. (2008), ‘Diffusion of new technology and payment policies: coronary stents’, Health Affairs, 27: 15661576.
Smith, J. J., Maida, A. and Henderson, J. A. (2002), ‘Hospital outpatient prospective payment under Medicare: Understanding the system and its implications’, Radiology, 225: 1319.
Sorenson, C. and Kanavos, P. (2008), Financing Medical Devices in France and the UK, Brussels: European Health Technology Institute for Socio-Economic Research.
Street, A., Kobel, C., Renaud, T. and Thuilliez, J. (2012), ‘How well do diagnosis-related groups explain variations in costs or length of stay among patients and across hospitals? Methods for analyzing routine patient data’, Health Economics, 21(S2): 618.
Street, A. and Maynard, A. (2007), ‘Activity based financing in England: the need for continual refinement of payment by results’, Health Economics, Policy and Law, 2(4): 419427.
Street, A., Vitikainen, K., Bjorvatn, A. and Hvenegaard, A. (2007), ‘Introducing activity-based financing: a review of experience in Australia, Denmark, Norway and Sweden’, CHE Research Paper 20. York: University of York.
Sussex, J. and Farrar, S. (2009), ‘Activity-based funding for National Health Service hospitals in England: managers’ experience and expectations’, European Journal of Health Economics, 10(2): 197206.
Torbica, A. and Cappellaro, G. (2010), ‘Uptake and diffusion of medical technology innovation in Europe: What role for funding and procurement policies?’, Journal of Medical Marketing, 10(1): 6169.
Weisbrod, B. A. (1991), ‘The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment’, Journal of Economic Literature, 29: 523532.

Related content

Powered by UNSILO

The role of hospital payments in the adoption of new medical technologies: an international survey of current practice

  • Corinna Sorenson (a1), Michael Drummond (a2), Aleksandra Torbica (a3), Giuditta Callea (a4) and Ceu Mateus (a5)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.